MAM
Melqart Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-150,000
| Closed | -$32.9M | – | 91 |
|
|
2021
Q4 | $32.9M | Buy |
150,000
+10,000
| +7% | +$2.2M | 1.67% | 13 |
|
|
2021
Q3 | $25.4M | Sell |
140,000
-138,130
| -50% | -$25.1M | 1.22% | 22 |
|
|
2021
Q2 | $56.1M | Buy |
278,130
+8,730
| +3% | +$1.76M | 2.52% | 13 |
|
|
2021
Q1 | $57.9M | Buy |
269,400
+128,100
| +91% | +$27.5M | 2.62% | 10 |
|
|
2020
Q4 | $33.4M | Buy |
141,300
+47,800
| +51% | +$11.3M | 2.52% | 14 |
|
|
2020
Q3 | $25.4M | Buy |
93,500
+15,500
| +20% | +$4.22M | 2.83% | 8 |
|
|
2020
Q2 | $22.6M | Sell |
78,000
-2,000
| -3% | -$581K | 2.8% | 9 |
|
|
2020
Q1 | $19M | Sell |
80,000
-207,900
| -72% | -$49.5M | 1.88% | 16 |
|
|
2019
Q4 | $63M | Buy |
287,900
+127,900
| +80% | +$28M | 5.28% | 7 |
|
|
2019
Q3 | $27.1M | Buy |
160,000
+16,000
| +11% | +$2.71M | 2.46% | 15 |
|
|
2019
Q2 | $26.4M | Buy |
144,000
+11,500
| +9% | +$2.11M | 1.82% | 19 |
|
|
2019
Q1 | $24.4M | Sell |
132,500
-22,500
| -15% | -$4.14M | 2.26% | 14 |
|
|
2018
Q4 | $25.7M | Buy |
+155,000
| New | +$25.7M | 3% | 12 |
|
|
2018
Q3 | – | Sell |
-184,800
| Closed | -$31.4M | – | 26 |
|
|
2018
Q2 | $31.4M | Buy |
+184,800
| New | +$31.4M | 2.68% | 13 |
|